Pulse wins IDE approval; Galvanize pulls in $100M

Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named  a new CEO, and PFA pioneer Steven Mickelsen has launched another company.

Scroll to Top